Calcineurin-independent regulation of plasma membrane Ca2+ATPase-4 in the vascular smooth muscle cell cycle

Abstract

Calcineurin mediates repression of plasma membrane Ca2+-ATPase-4 (PMCA4) expression in neurons, whereas c-Myb is known to repress PMCA1 expression in vascular smooth muscle cells (VSMC). Here, we describe a novel mouse VSMC line (MOVAS) in which45Ca efflux rates decreased 50%, fura 2-AM-based intracellular Ca2+concentrations ([Ca2+]i) increased twofold, and real-time RT-PCR and Western blot revealed a ∼40% decrease in PMCA4 expression levels from G0to G1/S in the cell cycle, where PMCA4 constituted ∼20% of total PMCA protein. Although calcineurin activity increased fivefold as MOVAS progressed from G0to G1/S, inhibition of this increase with either BAPTA or retroviral transduction with peptide inhibitors of calcineurin (CAIN), or its downstream target nuclear factor of activated T cells (NFAT) (VIVIT), had no effect on the repression of PMCA4 mRNA expression at G1/S. By contrast, Ca2+-independent activity of the calmodulin-dependent protein kinase-II (CaMK-II) increased eightfold as MOVAS progressed from G0to G1/S, and treatment with an inhibitor of CaMK-II (KN-93) or transduction of a c-Myb-neutralizing antibody significantly alleviated the G1/S-associated repression of PMCA4. These data show that G1/S-specific PMCA4 repression in proliferating VSMC is brought about by c-Myb and CaMK-II and that calcineurin may regulate cell cycle-associated [Ca2+]ithrough alternate targets.